Revenio Group (REG1V) Q2 2025 earnings summary

Executive summary

• Q2 2025 net sales grew 4.2% year-over-year (7.2% currency-adjusted) to EUR 26.5 million, with all regions and product categories contributing, especially APAC and Europe, notably India, France, and Germany.

• EBIT for Q2 reached EUR 6.1 million, up 16.2% year-over-year, and profitability improved across the board despite a challenging geopolitical environment.

• First half net sales were EUR 52.6 million, up 7.2% reported and 9.6% currency-adjusted, with operating profit at EUR 12.7 million (24.2% of net sales).

• MAIA microperimeter and ILLUME-based screening solutions launched and performed strongly, receiving marketing authorizations in key markets.

• Cash flow from operations improved to EUR 6.7 million in Q2 and EUR 11.4 million in H1, aided by effective working capital management.

Financial highlights

• Q2 net sales: EUR 26.5 million (+4.2%); H1 net sales: EUR 52.6 million (+7.2%); Q2 gross margin: 72.6%; H1 gross margin: 72.6%.

• Q2 EBIT: EUR 6.1 million (+16.2%); H1 EBIT: EUR 12.7 million (+22.3%).

• EBITDA for Q2 was EUR 7.2 million; H1 EBITDA was EUR 15.0 million (28.4% of net sales), up 12.5% year-over-year.

• EPS for Q2 was EUR 0.116; H1 EPS was EUR 0.273, impacted by unrealized FX losses.

• Cash and cash equivalents at period end were EUR 14.0 million; net debt at period end was EUR -1.3 million.

Outlook and guidance

• Guidance reiterated: exchange rate-adjusted net sales expected to grow 6–15% year-over-year in 2025; profitability (excluding non-recurring items) to remain at a good level.

• Demand and order backlog visibility remain short, but Q3 and Q4 are expected to be similar to Q2 with stable demand.

• Management notes continued uncertainty and volatility in the macroeconomic and geopolitical environment.